Search CommunityWalk:


Ravgen, Inc.

9241 Rumsey Road
Columbia, MD 21045, USA

Category: Diagnostic/Imaging

Used in the following map:

Maryland Biotech Industry Map

Ravgen, Inc. specializes in the scientific expertise of prenatal diagnostic testing. It was founded in 2000 by Ravinder Dhallan, with a mission to provide state of the art genetic testing that will enrich the lives of its patients.

Ravgen is focused on developing safe, noninvasive, pre-birth testing alternatives for expectant mothers. The company's core technology is based on its ability to increase the percentage of fetal DNA that is found in the mother's blood. Through its research with free floating fetal DNA, the company has developed and patented a variety of noninvasive prenatal tests that simply require a safe blood draw from the mother. Its core technology is focused on testing for single gene disorders, such as cystic fibrosis, sickle cell anemia, and the Jewish panel, as well as paternity testing disease.

Ravgen's patented, core technology the Ravgen Method is developed to diagnose disease using the unique genetic signature carried by each individual. Its Ravgen Method is developed by combining three important concepts that include: (1) using formaldehyde to enrich fetal DNA, which is present in maternal blood during pregnancy, (2) using SNPs to distinguish maternal DNA from fetal DNA and (3) calculating a ratio at heterozygous SNPs to determine chromosome copy number.